CASPOFUNGIN vs CATEQUENTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CASPOFUNGIN vs CATEQUENTINIB: Safety Overview
| Metric | CASPOFUNGIN | CATEQUENTINIB |
|---|---|---|
| Total FAERS Reports | 3,814 | 324 |
| Deaths Reported | 1,419 | 44 |
| Death Rate | 37.2% | 13.6% |
| Hospitalizations | 1,638 | 115 |
| Average Patient Age | 47.5 yrs | 57.2 yrs |
| % Female Patients | 42.8% | 38.7% |
| FDA Approval Date | Dec 30, 2016 | N/A |
| Manufacturer | Sandoz Inc | N/A |
| Route | INTRAVENOUS | N/A |
| Marketing Status | Discontinued | N/A |